Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
Ruiz Garcia, V., Burls, A., Cabello Lopez, J. C. L. , Fry-Smith, A., Munoz, J. G. G., Jobanputra, P. & Saiz Cuenca, E. S. C. (2009). Certolizumab pegol (CDP870) for rheumatoid arthritis in adults. Cochrane Database of Systematic Reviews(1), article number CD007649. doi: 10.1002/14651858.cd007649
Abstract
This is the protocol for a review and there is no abstract. The objectives are as follows:
To determine the efficacy and safety of certolizumab pegol (CDP870) and if it has clinical benefits for people with rheumatoid arthritis (RA) who do not respond well to conventional disease-modifying anti-rheumatic drugs (DMARDs).
| Publication Type: | Article |
|---|---|
| Subjects: | R Medicine > RC Internal medicine |
| Departments: | School of Health & Psychological Sciences |
| SWORD Depositor: |
Preview
Download (163kB) | Preview
Export
Downloads
Downloads per month over past year
Metadata
Metadata
MetadataAltmetric
CORE (COnnecting REpositories)
Actions (login required)
Actions (login required)
Admin Login